What is the primary driver of the significant revenue increase?

The substantial increase in revenue is primarily driven by the inclusion of the results from the merger with WellPoint Health Networks (WHN), which was completed on November 30, 2004. On a comparable basis, excluding the merger's impact, the company still demonstrated healthy revenue growth of 6%.

What is the significance of the announced merger with WellChoice, Inc.?

The announced merger with WellChoice, Inc., valued at approximately $6.5 billion, is a major strategic move that is expected to significantly expand Elevance Health's (then WellPoint, Inc.) market presence, particularly in New York. It will increase the combined company's medical membership to over 33 million and is anticipated to close in the first quarter of 2006.

How is the company managing its cost of care?

The company is actively managing its cost of care through various initiatives. This includes disciplined pricing, moderating cost trends, promoting performance-based contracts, expanding radiology management and disease management programs, and optimizing drug formularies. The benefit expense ratio improved to 79.9% from 82.7% year-over-year, reflecting these efforts.

What is the impact of the pending adoption of FAS 123R (Share-Based Payment) on the company's earnings?

The company expects that the adoption of FAS 123R, which requires companies to recognize share-based payments at fair value, will reduce its earnings by approximately 3% to 5% in 2006, based on its current stock-based compensation programs.

ELV 10-Q Quarterly Report Q3 FY2005 — Revenue, Net Income, EPS

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) reported strong financial performance for the quarter ended September 30, 2005. Total revenues surged by 135% to $11.3 billion, primarily driven by the significant integration of WellPoint Health Networks (WHN) which closed in late 2004. Excluding the impact of the merger, on a comparable basis, revenues grew a healthy 6% year-over-year, indicating robust underlying business expansion. Net income for the quarter more than doubled to $640.7 million, or $1.02 per diluted share, reflecting improved operational efficiencies and the accretive impact of the WHN acquisition. The company also announced a significant pending merger with WellChoice, Inc., valued at approximately $6.5 billion, which is expected to further solidify its market position. Investors should note the company's continued focus on strategic growth through acquisitions and its ongoing efforts to manage healthcare costs and enhance member services.

Key Highlights

1Total revenues increased significantly to $11.3 billion for the quarter ended September 30, 2005, a 135% increase year-over-year, largely due to the inclusion of WellPoint Health Networks (WHN) results.
2On a comparable basis (excluding merger impacts), total revenues grew 6% year-over-year, demonstrating underlying business growth.
3Net income more than doubled to $640.7 million for the quarter, resulting in diluted earnings per share of $1.02, up from $0.85 in the prior year.
4The company announced a definitive merger agreement with WellChoice, Inc. for approximately $6.5 billion, expected to close in Q1 2006.
5Total medical membership increased by 6% year-over-year to 28.9 million, with notable growth in self-funded memberships and BlueCard programs.
6Benefit expense as a percentage of premiums (benefit expense ratio) improved to 79.9% from 82.7% in the prior year, indicating better cost management.
7Selling, general, and administrative expenses as a percentage of operating revenue (SG&A ratio) saw a slight increase to 16.6% from 16.5%, attributed to merger-related costs and IT transition expenses.

Elevance Health, Inc. Quarterly Report for Q3 Ended Sep 30, 2005

Summary

Key Highlights

Frequently Asked Questions